CDR2L anticorps (C-Term)
Aperçu rapide pour CDR2L anticorps (C-Term) (ABIN927484)
Antigène
Reactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Purification
- Purified
-
Immunogène
- CDR2 L antibody was raised in rabbit using the C terminal of CDR2 as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
CDR2L Blocking Peptide, (ABIN5612804), is also available for use as a blocking control in assays to test for specificity of this CDR2L antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- CDR2L (Cerebellar Degeneration-Related Protein 2-Like (CDR2L))
-
Autre désignation
- CDR2L
-
Sujet
- The function of CDR2L remains unknown. Synonyms: Polyclonal CDR2L antibody, Anti-CDR2L antibody, cerebellar degeneration-related protein 2-like antibody, HUMPPA antibody.
Antigène
-